Page
%P
-
Article
Open AccessFulminant myocarditis during postoperative adjuvant chemotherapy for lung cancer with atezolizumab: a case report
Postoperative adjuvant systemic therapy with atezolizumab for lung cancer has been reported to be effective. Although myocarditis is a rare immune adverse event associated with atezolizumab, it can have a seri...